Treatment options in hypoparathyroidism

ABSTRACT Hypoparathyroidism remains the single endocrine deficiency disease that is not habitually treated with the missing hormone. In this article, we aim to provide a review of the conventional approach and the novel therapies as well as an overview of the perspectives on the treatment of this rare condition. We conducted a literature review on the conventional therapy using vitamin D analogs and calcium salts, indications for thiazide diuretics and phosphorus binders, PTH analogs history and usage, and the drugs that are currently being tested in clinical trials. Conventional treatment involves calcium salts and vitamin D analogs. Thiazide diuretics can be used to reduce hypercalciuria in some cases. A low-phosphate diet is recommended, and phosphate binders are rarely needed. During pregnancy, a careful approach is necessary. The use of PTH analogs is a new approach despite the limitation of high cost. Studies have included modified PTH molecules, calcilytics, microencapsulation of human parathyroid cells, and allotransplantation.

Guardado en:
Detalles Bibliográficos
Autores principales: Sakane,Eliane Naomi, Vieira,Maria Carolina Camargo, Vieira,Gabriela Mazzarolo Marcondes, Maeda,Sergio Setsuo
Formato: Digital revista
Idioma:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2022
Acceso en línea:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000500651
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S2359-39972022000500651
record_format ojs
spelling oai:scielo:S2359-399720220005006512022-11-30Treatment options in hypoparathyroidismSakane,Eliane NaomiVieira,Maria Carolina CamargoVieira,Gabriela Mazzarolo MarcondesMaeda,Sergio Setsuo Hypoparathyroidism treatment PTH analogs vitamin D perspectives ABSTRACT Hypoparathyroidism remains the single endocrine deficiency disease that is not habitually treated with the missing hormone. In this article, we aim to provide a review of the conventional approach and the novel therapies as well as an overview of the perspectives on the treatment of this rare condition. We conducted a literature review on the conventional therapy using vitamin D analogs and calcium salts, indications for thiazide diuretics and phosphorus binders, PTH analogs history and usage, and the drugs that are currently being tested in clinical trials. Conventional treatment involves calcium salts and vitamin D analogs. Thiazide diuretics can be used to reduce hypercalciuria in some cases. A low-phosphate diet is recommended, and phosphate binders are rarely needed. During pregnancy, a careful approach is necessary. The use of PTH analogs is a new approach despite the limitation of high cost. Studies have included modified PTH molecules, calcilytics, microencapsulation of human parathyroid cells, and allotransplantation.info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArchives of Endocrinology and Metabolism v.66 n.5 20222022-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000500651en10.20945/2359-3997000000554
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Sakane,Eliane Naomi
Vieira,Maria Carolina Camargo
Vieira,Gabriela Mazzarolo Marcondes
Maeda,Sergio Setsuo
spellingShingle Sakane,Eliane Naomi
Vieira,Maria Carolina Camargo
Vieira,Gabriela Mazzarolo Marcondes
Maeda,Sergio Setsuo
Treatment options in hypoparathyroidism
author_facet Sakane,Eliane Naomi
Vieira,Maria Carolina Camargo
Vieira,Gabriela Mazzarolo Marcondes
Maeda,Sergio Setsuo
author_sort Sakane,Eliane Naomi
title Treatment options in hypoparathyroidism
title_short Treatment options in hypoparathyroidism
title_full Treatment options in hypoparathyroidism
title_fullStr Treatment options in hypoparathyroidism
title_full_unstemmed Treatment options in hypoparathyroidism
title_sort treatment options in hypoparathyroidism
description ABSTRACT Hypoparathyroidism remains the single endocrine deficiency disease that is not habitually treated with the missing hormone. In this article, we aim to provide a review of the conventional approach and the novel therapies as well as an overview of the perspectives on the treatment of this rare condition. We conducted a literature review on the conventional therapy using vitamin D analogs and calcium salts, indications for thiazide diuretics and phosphorus binders, PTH analogs history and usage, and the drugs that are currently being tested in clinical trials. Conventional treatment involves calcium salts and vitamin D analogs. Thiazide diuretics can be used to reduce hypercalciuria in some cases. A low-phosphate diet is recommended, and phosphate binders are rarely needed. During pregnancy, a careful approach is necessary. The use of PTH analogs is a new approach despite the limitation of high cost. Studies have included modified PTH molecules, calcilytics, microencapsulation of human parathyroid cells, and allotransplantation.
publisher Sociedade Brasileira de Endocrinologia e Metabologia
publishDate 2022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000500651
work_keys_str_mv AT sakaneelianenaomi treatmentoptionsinhypoparathyroidism
AT vieiramariacarolinacamargo treatmentoptionsinhypoparathyroidism
AT vieiragabrielamazzarolomarcondes treatmentoptionsinhypoparathyroidism
AT maedasergiosetsuo treatmentoptionsinhypoparathyroidism
_version_ 1756472062171414528